ONEOK Reports Q3 with Shorts at Lows and Borrow Wide Open
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
ONEOK has just delivered its Q3 earnings report, and the setup heading into the print proved accurate: shorts at multi-month lows, borrow conditions deeply relaxed, and a stock that added 3.4% on the week to $96.01.
The short-side retreat that has defined the past six weeks is now confirmed data rather than a directional call. Short interest ended the week at 3.66% of free float, down 16% over the past month and a long way below the mid-September peak of around 31.7 million shares. The two-day uptick in the final days before the print has now reversed, with Tuesday's reading the lowest in the sequence. Borrow conditions remain among the loosest in the midstream sector. Availability has actually loosened further this week, jumping 22% to reach 630%, meaning there are more than six shares available for every one currently lent out. Cost to borrow is 0.49%, down 11% on the week and at the low end of the range that has held all autumn. Nothing in the lending market registers concern. The ORTEX short score is 46.3, broadly neutral, and has been flat for two weeks.
Options positioning is equally calm. Calls outnumber puts by a wide margin, with the put/call ratio at 0.35. That is modestly above the 20-day average of 0.34, by less than one standard deviation, and barely worth flagging relative to the 52-week high of 0.60. The retail attention signal from Wikipedia views carries a z-score of 2.17 against ONEOK's own 90-day history, the highest reading in the alt-data set, which suggests name recognition has ticked up around the earnings event. This is an attention measure, not a revenue indicator.
The Street's read on ONEOK has been broadly constructive. The stock's dividend score ranks in the 89th percentile across the universe, reflecting the income-yield argument that has anchored midstream demand. The earnings yield factor score sits at the 66th percentile. Value and quality metrics are more mixed: EV/EBITDA has compressed slightly over the past month, moving from 10.73 to 10.25, while the PE ratio has expanded from 14.34 to 15.87 as the stock has rallied. Recent prior notes flagged the 26.8% year-to-date gain and the debate over whether synergy targets from recent acquisitions are achievable. Bulls point to the 80% NGL-focused growth backlog and the forward yield. Bears question the EBITDA projections on the Brazos integration. The Q3 print itself is the next data point in that debate.
Institutional holders have been adding steadily. State Street added 2.1 million shares in the quarter to September, reaching a 6.9% stake. Capital Research increased by 4.8 million shares to 3.8% of shares outstanding. Charles Schwab Investment Management added 1.5 million shares. BlackRock remains the largest single holder at 9.6%, though its most recent 13G/A amendment disclosed a holding that has since moved. All 13D/G stakes are as-last-disclosed around the 5% threshold, and holders dropping below that level may not file again.
What to watch next is whether the Q3 result shifts any of the settled positioning. Short interest has been falling for six weeks, availability is near its loosest level of the past month, and the stock has run 8% over October. The question the print answers is whether the synergy and EBITDA trajectory justifies the re-rating, or whether some of the short covering now reverses.
Stocks in this article
See the live data behind this article on ORTEX.
Open OKE on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 18:43
- Data as of
- 28 Oct 2026, 18:34
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.